Online inquiry

IVTScrip™ mRNA-Human ARRDC2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26879MR)

This product GTTS-WK26879MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARRDC2 protein. This product can be used in FGFR1 Low NME5- epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001025604.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 27106
UniProt ID Q8TBH0
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARRDC2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26879MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK17912MR IVTScrip™ mRNA-Human ANKRD26P3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD26P3
GTTS-WK27056MR IVTScrip™ mRNA-Human ARAP1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARAP1
GTTS-WK25924MR IVTScrip™ mRNA-Human ARID3B, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARID3B
GTTS-WK25006MR IVTScrip™ mRNA-Human ARHGEF1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF1
GTTS-WK19123MR IVTScrip™ mRNA-Human ANKRD37, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD37
GTTS-WK26801MR IVTScrip™ mRNA-Human ARHGAP5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP5
GTTS-WK5634MR IVTScrip™ mRNA-Human HGAL, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA HGAL
GTTS-WK26828MR IVTScrip™ mRNA-Human ARID5B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARID5B
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW